ENFN - Enfusion - Stock Forecast

Technology - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ENFN is currently covered by 6 analysts with an average price target of $11.2. This is a potential upside of $1.1 (10.89%) from yesterday's end of day stock price of $10.1.

Enfusion's activity chart (see below) currently has 27 price targets and 31 ratings on display. The stock rating distribution of ENFN is 13.33% BUY, 66.67% HOLD and 20% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.64% with an average time for these price targets to be met of 64.63 days.

Highest price target for ENFN is $10, Lowest price target is $8, average price target is $11.2.

Most recent stock forecast was given by KOJI IKEDA from BAML on 13-Mar-2024. First documented stock forecast 15-Nov-2021.

Currently out of the existing stock ratings of ENFN, 2 are a BUY (13.33%), 10 are a HOLD (66.67%), 3 are a SELL (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$9

$-0.79 (-8.07%)

$10

8 months 8 days ago
(13-Mar-2024)

2/4 (50%)

$-0.32 (-3.43%)

87

Sell

$8

$-1.79 (-18.28%)

$10

8 months 24 days ago
(28-Feb-2024)

3/5 (60%)

$-0.73 (-8.36%)

114

Sell

$9

$-0.79 (-8.07%)

$12

9 months 22 days ago
(30-Jan-2024)

1/2 (50%)

$0.97 (12.08%)

17

Hold

$10

$0.21 (2.15%)

$9

11 months 1 days ago
(20-Dec-2023)

2/3 (66.67%)

$0.35 (3.63%)

57

Hold

$9

$-0.79 (-8.07%)

$11

1 years 14 days ago
(07-Nov-2023)

2/7 (28.57%)

$0.4 (4.65%)

25

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ENFN (Enfusion) average time for price targets to be met?

On average it took 64.63 days on average for the stock forecasts to be realized with a an average price target met ratio 39.64

Which analyst has the current highest performing score on ENFN (Enfusion) with a proven track record?

GABRIELA BORGES

Which analyst has the current lower performing score on ENFN (Enfusion) with a proven track record?

ALEXEI GOGOLEV

Which analyst has the most public recommendations on ENFN (Enfusion)?

Gabriela Borges works at GOLDMAN SACHS and has 8 price targets and 5 ratings on ENFN

Which analyst is the currently most bullish on ENFN (Enfusion)?

Parker Lane with highest potential upside - $7.39

Which analyst is the currently most reserved on ENFN (Enfusion)?

Gabriela Borges with lowest potential downside - -$1.79

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?